Trials / Completed
CompletedNCT00445107
SINGULAIR (R) as Complementary Therapy to Fixed Association Regimen (0476-363)
An Open Label, Observational Study to Assess The Efficacy, Safety and Tolerability of Added Singulair in Persistent Asthma Patients With or Without Allergic Rhinitis and Long Acting B-Agonist
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 198 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- All
- Age
- 15 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the treatment effect of montelukast 10mg on the primary endpoint of Asthma Control Questionnaire(ACQ), over a 8-week period, in persistent asthma patients with or without allergic rhinitis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MK0476, montelukast sodium / Duration of Treatment: 8 Weeks |
Timeline
- Start date
- 2005-11-01
- Primary completion
- 2006-05-01
- Completion
- 2006-05-17
- First posted
- 2007-03-08
- Last updated
- 2024-08-15
Source: ClinicalTrials.gov record NCT00445107. Inclusion in this directory is not an endorsement.